CUAMC
BEAM icon

China Universal Asset Management Company’s Beam Therapeutics BEAM Stock Holding History

China Universal Asset Management Company’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$431K Buy
18,075
+1,540
+9% +$42.7K 0.03% 269
2025
Q4 		$458K Sell
16,535
-9,197
-36% -$235K 0.04% 265
2025
Q3 		$625K Buy
25,732
+5,535
+27% +$110K 0.05% 223
2025
Q2 		$344K Buy
20,197
+3,175
+19% +$55.3K 0.03% 274
2025
Q1 		$332K Sell
17,022
-772
-4% -$20.2K 0.03% 277
2024
Q4 		$441K Buy
17,794
+1,707
+11% +$43.6K 0.04% 261
2024
Q3 		$394K Buy
16,087
+6,181
+62% +$160K 0.04% 242
2024
Q2 		$232K Sell
9,906
-6,013
-38% -$148K 0.03% 218
2024
Q1 		$526K Buy
15,919
+6,252
+65% +$195K 0.07% 178
2023
Q4 		$263K Buy
9,667
+7,395
+325% +$184K 0.05% 185
2023
Q3 		$54.6K Buy
2,272
+1,037
+84% +$27.8K 0.02% 228
2023
Q2 		$39.4K Buy
1,235
+18
+1% +$584 0.01% 216
2023
Q1 		$37.3K Buy
1,217
+265
+28% +$10.5K 0.01% 173
2022
Q4 		$37.2K Buy
952
+57
+6% +$2.55K 0.02% 147
2022
Q3 		$43K Buy
+895
New +$51.1K 0.02% 127

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

China Universal Asset Management Company's BEAM Position: Q1 2026 in Review

China Universal Asset Management Company increased its Beam Therapeutics (BEAM) stake by 9.3% in Q1 2026, buying an estimated $42.7K and bringing the position to 18,075 shares worth $431K. The position accounts for 0.03% of the portfolio, ranked #269.

China Universal Asset Management Company first reported a position in BEAM in Q3 2022 and has held it in 15 quarters since. The position peaked at $625K in Q3 2025. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • China Universal Asset Management Company held 18,075 shares of Beam Therapeutics worth $431K as of Q1 2026.
  • China Universal Asset Management Company bought 1,540 Beam Therapeutics shares in Q1 2026, an estimated $42.7K.
  • Beam Therapeutics made up 0.03% of China Universal Asset Management Company's portfolio in Q1 2026, its #269 holding.
  • China Universal Asset Management Company first reported a position in Beam Therapeutics in Q3 2022 and has held it in 15 quarters since.
  • China Universal Asset Management Company's Beam Therapeutics position peaked at $625K in Q3 2025.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on China Universal Asset Management Company's 13F filing for Q1 2026, filed 28 Apr 2026.